The European Stroke Network

Similar documents
Sabrina Jedlicka 9/24/2012. NEUROENGINEERING: Interactions of Neurons and Materials

Hypoxic Preconditioning Strategy for Stem Cell Transplantation Therapy after Ischemic Stroke

Developing Targeted Stem Cell Therapeutics for Cancer. Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013

Profibrinolytic diabody targeting PAI-1 and TAFI for treatment of acute thrombotic disorders

Concept of Integrated Research Platforms

leading the way in research & development

for SCI: Challenges for Entry and Execution of Phase 1 Clinical Trials Challenges and Opportunities of Cellular Therapeutic Development

Handy Gelbard, Director Professor of Neurology, Pediatrics, Microbiology & Immunology and Neuroscience

Myelin Repair Foundation Research Progress Report June 2006-July 2007

Cell-penetrating peptides: news for dated cellular Trojan horses

Growth factor delivery

UNCLASSIFIED R-1 ITEM NOMENCLATURE

SmartPReP 2: The Gold Standard

Project Final Report

Preclinical development for SSc indications NO COPY. a preclinical portfolio in a perfect world. Jörg Distler

OMM Research From Bedside to Bench and Back Again. Dr. Rzigalinski - DrZ

At the conclusion of this lesson you should be able to:

Marie Skłodowska-Curie European Fellowship

THE SCIENCE OF PLATELET RICH PLASMA

Article: "Noninvasive and Targeted Gene Delivery into the Brain Using Microbubble-Facilit 1 / 16. Ultrasound" Malova Anna

J ove VIDEO JOURNAL CATALOG A CATALYST FOR SCIENTIFIC RESEARCH AND EDUCATION

The Cell and Gene Therapy Catapult UK clinical trials database

Tissue Engineering and the Brain. Susan Perry Bioengineering Program Lehigh University

Structure of IgG and IgM

FOR 2325 Interactions at the Neurovascular Interface. International Symposium. Cellular and Molecular Processes at the Neurovascular Interface

STEM CELLS IN NEUROLOGY ISABELLE COCHRANE MERIT

KRISANI BIO SCIENCES PVT. LTD.

The Cell and Gene Therapy Catapult UK clinical trials database

Office of Patents and Licensing STEM CELLS & TISSUE ENGINEERING

UNCLASSIFIED UNCLASSIFIED

Insight Through In Vivo Imaging

Stem Cel s Key Words:

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York

Tadanori Ogata 1, Hideki Horiuchi 1, Tadao Morino 1, Sintaro Yamaoka 1, Hiromasa Miura 2.

The Leader in AAV Gene Therapy. A Guide to AAV Gene Therapy for MPS I and II

A/Prof Bronwen Connor Neural Repair and Neurogenesis Lab Dept of Pharmacology & Clinical Pharmacology Centre for Brain Research University of

Cell membrane repair in acute lung injury: from bench to bedside. Disclosure. Cell membrane repair is an elemental physiological process

Translation of Biomaterial-based Therapies for the Treatment of Spinal Cord Injury: The Neuro-Spinal Scaffold and Bioengineered Neural Trails

QPS Neuropharmacology Overview

Gene therapy. Findings by Alert

Chapter 8 Healthcare Biotechnology

Biomedical Sciences (Medical) (BMSC)

Opportunities for industry/smes in EU-funded health research

EU support for Health Research from FP6 to FP7

FDA Regulatory, Compliance and Policy Developments: 361 HCT/Ps

Axol Bioscience SNAPSHOT PRESENTATION ELRIG ADVANCES IN CELL BASED SCREENING Zoe Allen, PhD Product Specialist

IV tpa: 1996 to Present

Cell and Gene Therapy Catapult clinical trials database

Preclinical MRI. Solutions for Small Animal Imaging. Molecular Imaging

Nanotechnology: A Brief History and Its Convergence with Medicine. Weston Daniel, PhD Director of Program Management

Research Strategy Delivering internationally excellent research for a healthy, safe and sustainable society

Stem Cells: Introduction and Prospects in Regenerative Medicine.

ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development

Outcomes in Mesenchymal Stem Cell Manufacturing. Athena Russell, MT(AAB) Human Cellular Therapy Laboratory Mayo Clinic Jacksonville, FL

Regulatory Challenges for the Development of Allogeneic Mesenchymal Stem Cell Products. Rod Monroy, Ph.D. Director, Prochymal

Barbara Alving, MD Director, National Center for Research Resources 6701 Democracy Boulevard MSC 4874 Bethesda, MD

OUR WISH LIST RESEARCH EQUIPMENT

OUR WISH LIST RESEARCH EQUIPMENT

NEURONAL CELL CULTURE MATRIX FOR BETTER MAINTENANCE AND SURVIVAL OF NEURONAL CELL CULTURES IN TISSUE CULTURE.

REIMAGINING DRUG DEVELOPMENT:

Stem Cells Canadian Perspective

Linker p. 177 Helper Lipid p. 178 Delivery to Target Cells p. 180 Cell Entry p. 182 Receptor-Mediated Uptake p. 182 Endosomai Release p.

Development of new polymeric biomaterials for in vitro and in vivo liver reconstruction

The Swedish Foundation for Strategic Research (SSF) announces a. call for proposals in the areas of

Stem cells and motor neurone disease

Molecular Medicine. Stem cell therapy Gene therapy. Immunotherapy Other therapies Vaccines. Medical genomics

Anika Therapeutics, Inc.


BUILT TO CONCENTRATE. Magellan is an autologous concentration system that delivers concentrated platelets and cells at the point of care.

List of E-journals Subscribed for the year 2016 (January to December) Pharmacy Faculty Sl. No.

Caplacizumab. Wholly-owned anti-vwf Nanobody

ALL THE ESSENTIALS OF HEALING, NATURALLY

Alex A. Aimetti, PhD Sr. Director, Medical Education October 29, InVivo Therapeutics

Research area in the Strategic Objective Development of optical control technologies and elucidation of biological mechanisms

All THE E SSEn TIAl S OF H EAl I ng, natu RAlly. P RIvATE PRACTICE

SCM Lifescience COMPANY PROFILE BUSINESS AREAS. [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea [Website]

Translational Research


The Cardiovascular System: Blood

A Physiological Cell based Microchip Platform. 1

UvA-DARE (Digital Academic Repository) Factor XI as target for antithrombotic therapy van Montfoort, M.L. Link to publication

BEH.462/3.962J Molecular Principles of Biomaterials Spring 2003

Production and commercialisation of vascularized and customized bone Clinical trials, market authorisation Pre-clinical trials

TOP ST. search articles. ' s. . Discovery brings with it possible implications for brain regeneration -

When should non human primates be used as animal models?

CRITERIA FOR PROJECT SELECTION

PRE-HOSPITAL AND PERIPROCEDURE NEUROPROTECTION: THE FAST AND THE FURIOUS. William J. Mack, MD, MS, FAANS, FAHA

1 Ultrasound targeting

Molecular Imaging. by Magnetic Resonance. Silvio Aime. University of Torino (Italy) Department of Chemistry IFM & Molecular Imaging Center

Jefferies Healthcare Conference 2016

Instructor: Laboratory Location: Contact Information: Website: Course Information: Research Interests: Instructor: Laboratory Location:

Characterization and Functional Analysis of a Newly Identified Human MT5-MMP Transcript Variant Isolated from Multipotent NT2 Cells

Promises and Challenges

Des cellules-souches dans le poumon : pourquoi faire?

Therapeutic Cell Replacement. Steven McLoon Department of Neuroscience University of Minnesota

Erectile and voiding dysfunction: will stem cells solve it all?

Therapeutic Cell Replacement. Steven McLoon Department of Neuroscience University of Minnesota

Adult Stem Cells for Chronic Pain. Dr. John Hughes, DO January 24 th, 2018

Stem Cell Services. Driving Innovation for Stem Cell Researchers

Transcription:

The European Stroke Network A Unique Alliance for Combating Stroke Prof. Dr. Stephen Meairs Department of Neurology University Medicine Mannheim University of Heidelberg, Germany

European Stroke Network 30 Partners from 14 countries

The European Stroke Network European Stroke Research Network (EUSTROKE) Coordinator: Prof. Stephen Meairs Affording Recovery in Stroke (ARISE) Coordinator: Prof. Ulrich Dirnagl www.europeanstrokenetwork.eu

European Stroke Network Launch by European Commission in 2008

Primary Goals decrease the physical, social and economic consequences of stroke on the individual and on society achieve this objective by bringing together European researchers, government, industry, the non-profit sector and patient group associations

Research Themes of ESN Neurovascular Unit Regeneration Reperfusion Brain Immune Interaction / Inflammation Prevention / Neuroprotection

ESN Platforms Clinical Trial Platform (SITS) Stroke Models Imaging Training Patient group interaction (SAFE)

Challenges and opportunities of FP7 research Multidisciplinary Research

Multidisciplinary Research Complex problems demand multidisciplinary approach Utilize the opportunity to integrate researchers new to a particular clinical field Results can be very rewarding Challenge: Requires intensive dialogue and training

Challenges and opportunities of FP7 research Added Value

European Added Value A Tangible Advantage Going beyond research at a national level Cross fertilization of European research centers can lead to better results European cooperation is superior Fresh approaches to a problem provide higher impact Training opportunities, new research impulses Challenge: to stimulate added value in project

Neurovascular Unit

strategies that reduce vascular causes of injury to the brain tissue have been the most successful therapeutic approaches to limiting the extent of injury from ischemic stroke. the microvascular component of the neurovascular unit contributes to neuronal injury

The neurovascular unit circulating blood elements highly specialized endothelial cells pericytes embedded in the endothelial cell basement membrane perivascular antigen presenting cells astrocytic endfeet parenchymal basement membrane neurons

Research focus on NVU little understanding of molecular biology of the NVU interdisciplinary barriers - researchers in the different fields of vascular biology, neurobiology, physiology and cell biology neurons, glia and vascular cells are closely related developmentally, structurally and functionally neurovascular unit highlights the intimate functional relationships between these cells and their coordinated pattern of reaction to injury

New Models for Studying the NVU help identify the cellular and molecular mechanisms involved in NVU maintenance provide a basis for understanding how ischemia leads to breakdown of the NVU understand how the NVU contributes to reperfusion injury

Regeneration

Regeneration and Repair after stroke Molecular and cellular regulation of stroke-induced neurogenesis from endogenous neural stem/progenitor cells. Dynamics of structural recovery of surviving neurons and proliferation of glia cells in relation to axonal growth and expression of molecules involved in trafficking Effects of an antibody against Nogo-A on enhancing functional recovery.

Angiogenesis and vascular stabilization define factors able to induce mobilization from the bone marrow of endothelial and myeloid cell progenitors assess the potential of ex vivo administered vascular progenitor cells in reducing cerebral damage after acute cerebral vessel occlusion define the adhesion molecules and chemokines able to mediate the homing of these cells in the ischemic brain

Angiogenesis and vascular stabilization identify the growth factors which induce angiogenesis in the brain while retaining permeability properties and induce vessel maturation elucidate the optimal interaction of newly growing vessels with pericytes and neural cells identify the bi-directional signals between neural stem cells and brain endothelial cells

Targeted gene therapy and nanotechnology Targeted gene delivery of AAV vectors to the brain with microbubbles and ultrasound Encapsulated biodelivery of SDF1, meteorin, and BDNF for fostering stem cell migration and differentiation using MR-guided focused ultrasound

Transient opening of BBB with focused ultrasound 9,4 Tesla Bruker BioSpec 94/20 USR, rat brain MRI parameters: Insonation characteristics: T1 FLASH Frequency 1 MHz TR: 70 Burst length 10 ms TE: 2 Burst rate 1 Hz ST: 0.5 2.5 MPa L: 16438 W: 32658 1 min insonation time Contrast agent: gadolinium (Gadovist )

Targeted delivery of AAV with focused ultrasound and lipoplex microbubbles Adeno-associated virus - Serotype raav2/1

Triggering regeneration in the brain Non-invasive targeted delivery of brain-derived neurotrophic factor to the brain with focused ultrasound and microbubbles Alexa488-BDNF 4h after ultrasound and microbubbles (BG6895) Rat brain cortex Vessel 80µm 20µm Left image: vessel (neg. for BDNF, left lower corner); multiple neurons staining strongly positive for BNDF (see arrows); punctuate staining possibly due to low uptake of BNDF in cells (not in control hemispheres!) Middle image: high magnification of neurons with very strong uptake of BNDF.

MR-guided Focused Ultrasound

Reperfusion

Neurotoxic effects of thrombolysis Identifying and testing nonneurotoxic thrombolytics Biomarkers to identify individual variability in response to thromboembolic arterial occlusion as well as risk of hemorrhage and neurotoxicity (microparticles)

Adjunct therapies for thrombolysis release tpa PAI-1 tpa activation pln a2-ap inhibition tpa plg pln inhibition Fibrin clot Breakdown FDPs Benchenane et al., Trends In Neurosciences, 2004

23Na concentration related intensity/ tissue vitality (T 2* -weighted 23Na MRI, Acquisition Time = 20min)

Immune Interaction / Inflammation

Inflammation in stroke Identify the efficacy of key anti-inflammatory strategies Determine the effect of systemic inflammation, investigate the mechanisms involved and explore new inflammatory biomarkers Test new inflammatory targets

Brain-immune interactions Explore the basic mechanisms of brain-immune interaction after stroke Establish predictive and sensitive clinical markers to describe the effect of stroke on the immune system

Prevention / Neuroprotection

Prevention of stroke via the NVU effects of functional foods and lipid-lowering drugs on NVU function and susceptibility to ischaemic stroke effects of physical exercise on the physiology of the neurovascular unit investigate whether physical activity and lipid-lowering influence endothelial progenitor cells, thus increasing susceptibility to stroke.

Endogenous neuroprotection Neuroprotective signaling Mechanisms of hypothermia induced neuroprotection Nasopharyngeal human brain cooling

Stroke model platform

Brain imaging platform

Training in stroke models and research

Close Cooperation between Experimental and Clinical Research

The ESN Trials Platform SITS Nils Wahlgren WSO Markku Kaste ESC Michael Hennerici ESO Werner Hacke TRANSLATION ESN Research Clinical Studies

Adapt the SITS network and database to support an ESN TRIALS PLATFORM (data entry and management, data sharing, etc) develop novel data entry procedures suitable for ambulatory use in prehospital settings and for acute phase intervention trials

Cooperation with Stroke Alliance for Europe

SAFE Activity in the ESN Engage in political efforts to foster government and EU funding of stroke research Assist in activities to raise private funds for support of future ESN research Support integration of national stroke research with the ESN to achieve high standards of European research